OSI Pharmaceuticals Inc.
(NASDAQ:OSIP)|
35.76 -1.44 (-3.87%) 3:05ET Delayed |
|
|
|
- Compare OSIP with:
- View: Line | Candlestick
Company Profile
OSI Pharmaceuticals Inc.
41 Pinelawn Road
Melville, NY 11747
United States - Map
Phone: (631) 962-2000
Fax: (631) 752-3880
Website: www.osip.com
State of incorporation: Delaware
CEO: Dr. Colin Goddard, Ph.D.
Employees: 488
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Mid-cap biotech co engaged in molecular therapies
A mid-cap biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies.
Recent news for OSIP
-
Business Wire - Nov 26 at 7:38 ET
-
Roche wins final UK okay for discounted Tarceva
Reuters - Nov 25 at 7:01 ET
-
OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday, December 4th
Business Wire - Nov 24 at 11:00 ET
-
Motley Fool - Nov 21 at 4:15 ET
-
OSI PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Nov 21 at 3:13 ET
-
Top Biotech Short-Squeeze Plays
TheStreet.com - Nov 21 at 11:49 ET
-
Top Biotech Short-Squeeze Plays
TheStreet.com - Nov 21 at 7:07 ET
-
AstraZeneca Gets The Legal Edge
Forbes.com - Nov 20 at 3:30 ET
-
Double Trouble for AstraZeneca
Motley Fool - Nov 20 at 2:15 ET
-
Business Wire - Nov 20 at 11:00 ET
Top members owning OSIP
-
Top 2%
-22.59%3m:
-22.59%YTD:
-
Top 73%
-45.42%3m:
-43.07%YTD:
-
Top 47%
-31.87%3m:
-31.45%YTD: